Skip to main content
Caplight Logo









DocSpera

DocSpera

Private
Sunnyvale, CaliforniaHealthcare & Life Scienceshttps://docspera.com/

Last Round

Series B

Sep 27, 2022

Total Funding Raised

$10M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DocSpera is a healthcare technology company that provides an integrated surgical coordination platform to streamline scheduling, communication, and planning across the surgical care lifecycle.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Data Integration, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service

AI Layer

Application

Keywords

surgical coordinationsurgical schedulingvertical SaaSelectronic health recordsEHRdata interoperabilitysurgical analyticsworkflow automationambulatory surgery centersASCmedical device inventoryMedTech softwarepatient trackinghealth techsupply chain coordinationpredictive schedulingOR optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DocSpera Comparables

Compare DocSpera with similar companies based on industry and business-model similarity.

DocSpera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Surgimate
85%
ReadySet Surgical
83%
PreferredMD
82%

DocSpera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 27, 2022
Series AJun 19, 2014

Key People

Founding team and executive leadership

Luca Santarella

Chief Technology Officer

Executive Team

DocSpera Investors

Notable investors and investment history

DocSpera investors
InvestorRounds
Pier 70 VenturesSeries B
Attractor Investment ManagementSeries A, Series B
Johnson & Johnson Innovation – JJDCSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 38% MoM, from 3.6K to 5K.

  • Jun 19, 2014

    Raised Series A round with Attractor Investment Management.

DocSpera Filings

Explore SEC and related filing metadata, where available.

DocSpera filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DocSpera's valuation, stock price, and market status.

Is DocSpera a public or private company?

DocSpera is a private company.

What is the current stock price of DocSpera?

DocSpera is a private company, so its shares have no public market price. Caplight tracks DocSpera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is DocSpera worth (valuation)?

Valuation information for DocSpera is not publicly available.

Can I buy DocSpera stock?

DocSpera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was DocSpera's last funding round?

DocSpera's most recent funding round was Series B on September 27, 2022.

Who are the main investors in DocSpera?

Key investors in DocSpera include Pier 70 Ventures, Johnson & Johnson Innovation – JJDC.

Will DocSpera IPO soon?

No public IPO plans have been announced for DocSpera.

How can I track DocSpera secondary market activity?

Caplight tracks bids, offers, and trades in DocSpera's shares on secondary markets.

Firmographic Details

HeadquartersSunnyvale, California
Employee Range14
Year Founded2014
Last FundingSep 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?